Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guilu Erxian Jiao for Intradialytic Hypotension
NCT06980922Phase 2Not yet recruiting
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jun 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gui-lu-er-xian-jiao-wan in intradialytic hypotension (IDH), sponsored by Chang Gung Memorial Hospital. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
gui-lu-er-xian-jiao-wan
03
Conditions
intradialytic hypotension (IDH)
Beyond the preview
Go deeper on NCT06980922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06980922.